Naurex Inc.
Susan Riley Leppard has extensive work experience in the field of clinical research. Susan Riley started their career at Roche in 1997 and worked as a CRA Manager until 2002. Susan then joined Global Research Services in 2009 as a Lead CRA, where they worked until 2010. Susan Riley later worked at ICON Clinical Research from 2006 to 2011 as a CRA Manager, responsible for managing 15 Clinical Research Associates, conducting quality assurance, and performing performance reviews. In 2013, they joined Naurex, Inc (now Aptinyx), and continued their role as Lead CRA / CRA Manager. Susan Riley is currently employed at Aptinyx in the same position.
Susan Riley Leppard completed their Bachelor of Science degree in Psychology and Business Management from the University of Maryland Global Campus from 1983 to 1986. It is also mentioned that they obtained a Bachelor of Science degree in Psychology and Business Management from the University of Maryland, although the specific duration of the program is not provided.
This person is not in any teams
This person is not in any offices
Naurex Inc.
Naurex Inc. is a clinical-stage company developing novel therapies for depression and other CNS disorders based on a new mechanism of action for modulating the N-methyl-D-aspartic acid receptor (NMDAR). Using these discoveries, Naurex researchers have generated novel chemical drug classes known as glycine-site functional partial agonists (GFPAs),which modulate the receptor in a different way than existing NMDAR agents. The company's drug development programs based on its GFPA NMDAR modulators include the first-generation molecule, GLYX-13, the second-generation NRX-1050 small molecule series and additional compounds from Naurex's platform of novel NMDAR modulators.